International summit on cutaneous antifungal therapy. Boston, Massachusetts, Nov. 11-13, 1994.
暂无分享,去创建一个
[1] J. Leyden. Tinea pedis pathophysiology and treatment. , 1994, Journal of the American Academy of Dermatology.
[2] G. Midgley,et al. Mycology of nail disorders. , 1994, Journal of the American Academy of Dermatology.
[3] D. Massart,et al. Two‐week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double‐blind, multicentre study , 1994, The British journal of dermatology.
[4] I. James,et al. Short‐duration therapy with terbinafine 1% cream in dermatophyte skin infections , 1994, The British journal of dermatology.
[5] E. Evans,et al. Comparison of terbinafine and clotrimazole in treating tinea pedis. , 1993, BMJ.
[6] D. Roseeuw,et al. New approaches to the treatment of onychomycosis. , 1993, Journal of the American Academy of Dermatology.
[7] H. Jones. Immune response and host resistance of humans to dermatophyte infection. , 1993, Journal of the American Academy of Dermatology.
[8] Hay Rj. Onychomycosis. Agents of choice. , 1993 .
[9] G. Nahass,et al. Onychomycosis: successful treatment with once-weekly fluconazole. , 1993, Dermatology.
[10] Y. Clayton. Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses , 1992, Clinical and experimental dermatology.
[11] J. V. van Cutsem,et al. Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis. , 1992, Journal of the American Academy of Dermatology.
[12] D. Roberts,et al. Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey , 1992, The British journal of dermatology.
[13] M. Goodfield. Short‐duration therapy with terbinafine for dermatophyteonychomycosis: A multicentre trial , 1992, The British journal of dermatology.
[14] M. Crijns,et al. A randomized treatment duration‐finding study of terbinafine in onychomycosis , 1992, The British journal of dermatology.
[15] K. Kuokkanen,et al. Fluconazole in the treatment of onychomycosis caused by dermatophytes , 1992 .
[16] E. Evans,et al. Successful 2‐week treatment with terbinafine (Lamisil®) for moccasin tinea pedis and tinea manuum , 1991, The British journal of dermatology.
[17] M. K. Moawad,et al. Fungal infection as a cause of skin disease in the Eastern Province of Saudi Arabia: tinea pedis and tinea manuum , 1991, Mycoses.
[18] R. Savin. Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis. , 1990, Journal of the American Academy of Dermatology.
[19] M. Goodfield. Clinical results with terbinafine in onychomycosis , 1990 .
[20] R. C. Summerbell,et al. Onychomycosis, Tinea Pedis and Tinea Manuum Caused by Non‐Dermatophytic Filamentous Fungi Nicht‐Dermatophyten‐Fadenpilze als Erreger von Onychomykosen, Tinea pedis und Tinea manuum , 1989, Mycoses.
[21] H. Gugnani,et al. Foot infections due to Hendersonula toruloidea and Scytalidium hyalinum in coal miners. , 1989, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[22] M. Dahl,et al. Inhibition of growth of Trichophyton rubrum by the myeloperoxidase-hydrogen peroxide-chloride system. , 1989, The Journal of investigative dermatology.
[23] R. Hay,et al. An evaluation of itraconazole in the management of onychomycosis , 1988, The British journal of dermatology.
[24] Alicja Budak,et al. Fungal Species Isolated from Skin and Nail Lesions of Hands and Feet of Patients Suspected of Mycotic Infection./Das Pilzartenspektrum an Haut‐ und Nagelläsionen der Hande und Füße von Patienten mit Mykoseverdacht , 1987, Mykosen.
[25] M. Dahl. Immunological resistance to dermatophyte infections. , 1987, Advances in dermatology.
[26] M. K. Moore,et al. Hendersonula toruloidea and Scytalidium hyalinum infections in London, England. , 1986, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[27] M. Dahl,et al. Polymorphonuclear leukocytes, complement, and Trichophyton rubrum. , 1986, The Journal of investigative dermatology.
[28] D. Hammerschmidt,et al. Complement activation by trichophyton rubrum. , 1983, The Journal of investigative dermatology.
[29] R. Hay,et al. Chronic dermatophyte infections II. Antibody and cell‐mediated immune responses , 1982, The British journal of dermatology.
[30] H. Jones,et al. Immediate and delayed hypersensitivity in chronic dermatophytosis. , 1976, Archives of dermatology.
[31] M. Rinaldi,et al. Model dermatophytosis in naturally infected subjects. , 1974, Archives of dermatology.
[32] M. Rinaldi,et al. Immunologic susceptibility to chronic dermatophytosis. , 1974, Archives of dermatology.
[33] M. Rinaldi,et al. Acquired immunity to dermatophytes. , 1974, Archives of dermatology.
[34] E. Evans,et al. Foot Infections in Swimming Baths , 1973, British medical journal.
[35] M. English,et al. Studies in the Epidemiology of Tinea Pedis , 1959, British medical journal.
[36] J. Gentles,et al. Diagnosis of foot ringworm. , 1956, Lancet.